Steven Cohen’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
Steven Cohen's OVID Position: Q3 2026 in Review
Steven Cohen increased its Ovid Therapeutics (OVID) stake by 31% in Q3 2026, buying an estimated $1.58M and bringing the position to 2,549,273 shares worth $6.35M. The position accounts for 0.01% of the portfolio, ranked #1653.
Steven Cohen first reported a position in OVID in Q4 2025 and has held it in 4 quarters since. 127 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- Steven Cohen held 2,549,273 shares of Ovid Therapeutics worth $6.35M as of Q3 2026.
- Steven Cohen bought 603,546 Ovid Therapeutics shares in Q3 2026, an estimated $1.58M.
- Ovid Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1653 holding.
- Steven Cohen first reported a position in Ovid Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 127 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.